Skip to main content

Advertisement

SpringerLink
Log in

Small Bowel Tumors – Case Series Analysis: Prognostic Factors and Survivals

  • Original Article
  • Published:
Indian Journal of Surgery Aims and scope Submit manuscript

Abstract

Small intestinal malignancy is uncommon. The clinical characteristics vary with histologic subtype, and factors predictive of outcome are not well studied. A case series analysis of clinicopathologic data from patients undergoing small intestinal malignancy resection in our institution was used over a 6-year period. Kaplan Meier survival estimates were compared using Log-rank and survival curves constructed. Multivariate analysis enabled determination of factors predictive of outcome. Eighty-seven patients were included; 24 required emergency surgery and neuroendocrine (NET) was the most common histological subtype. NETs were significantly smaller than adenocarcinomas or gastrointestinal stromal tumors (GISTs); however, a greater proportion of NETS had metastatic disease, perineural invasion and underwent R1 resection. Despite their advanced stage at presentation, NETs demonstrated favorable outcome compared with other histologic subtypes. Tumor grade, neuroendocrine histology and nodal metastasis were all independently associated with overall survival. Despite the advanced stage of NETs at presentation, these tumors demonstrated better overall survival than adenocarcinomas or GISTs. De-bulking with R1 resection is an acceptable approach for NET as compared to adenocarcinoma or GIST. Future work needs to focus on the development of targeted therapies for small intestinal adenocarcinoma to improve long-term outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Aparicio T, Zaanan A, Svrcek M, Laurent-Puig P, Carrere N, Manfredi S, Locher C, Afchain P (2014) Small bowel adenocarcinoma: epidemiology, risk factors, diagnosis and treatment. Dig Liver Dis 46:97–104. https://doi.org/10.1016/j.dld.2013.04.013

    Article  PubMed  Google Scholar 

  2. Pan SY, Morrison H (2011) Epidemiology of cancer of the small intestine. World J Gastrointest Oncol 3:33–42. https://doi.org/10.4251/wjgo.v3.i3.33

    Article  PubMed  PubMed Central  Google Scholar 

  3. Talamonti MS, Goetz LH, Rao S, Joehl RJ (2002) Primary cancers of the small bowel: analysis of prognostic factors and results of surgical management. Arch Surg Chic Ill 1960 137:564–570 discussion 570-571

    Google Scholar 

  4. Sakae H, Kanzaki H, Nasu J, Akimoto Y, Matsueda K, Yoshioka M, Nakagawa M, Hori S, Inoue M, Inaba T, Imagawa A, Takatani M, Takenaka R, Suzuki S, Fujiwara T, Okada H (2017) The characteristics and outcomes of small bowel adenocarcinoma: a multicentre retrospective observational study. Br J Cancer 117:1607–1613. https://doi.org/10.1038/bjc.2017.338

    Article  PubMed  PubMed Central  Google Scholar 

  5. Ramage JK, Ahmed A, Ardill J, Bax N, Breen DJ, Caplin ME, Corrie P, Davar J, Davies AH, Lewington V, Meyer T, Newell-Price J, Poston G, Reed N, Rockall A, Steward W, Thakker RV, Toubanakis C, Valle J, Verbeke C, Grossman AB, UK and Ireland Neuroendocrine Tumour Society (2012) Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut 61:6–32. https://doi.org/10.1136/gutjnl-2011-300831

    Article  CAS  PubMed  Google Scholar 

  6. Pape U-F, Jann H, Müller-Nordhorn J, Bockelbrink A, Berndt U, Willich SN, Koch M, Röcken C, Rindi G, Wiedenmann B (2008) Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer 113:256–265. https://doi.org/10.1002/cncr.23549

    Article  PubMed  Google Scholar 

  7. Qubaiah O, Devesa SS, Platz CE, Huycke MM, Dores GM (2010) Small intestinal cancer: a population-based study of incidence and survival patterns in the United States, 1992 to 2006. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 19:1908–1918. https://doi.org/10.1158/1055-9965.EPI-10-0328

    Article  Google Scholar 

  8. Bilimoria KY, Bentrem DJ, Wayne JD, Ko CY, Bennett CL, Talamonti MS (2009) Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg 249:63–71. https://doi.org/10.1097/SLA.0b013e31818e4641

    Article  PubMed  Google Scholar 

  9. Cunningham JD, Aleali R, Aleali M, Brower ST, Aufses AH (1997) Malignant small bowel neoplasms: histopathologic determinants of recurrence and survival. Ann Surg 225:300–306

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Bauer RL, Palmer ML, Bauer AM, Nava HR, Douglass HO (1994) Adenocarcinoma of the small intestine: 21-year review of diagnosis, treatment, and prognosis. Ann Surg Oncol 1:183–188

    Article  CAS  PubMed  Google Scholar 

  11. Ojha A, Zacherl J, Scheuba C, Jakesz R, Wenzl E (2000) Primary small bowel malignancies: single-center results of three decades. J Clin Gastroenterol 30:289–293

    Article  CAS  PubMed  Google Scholar 

  12. Aydin D, Sendur MA, Kefeli U, Unal OU, Tastekin D, Akyol M, Tanrikulu E, Ciltas A, Ustaalioglu BB, Uysal M, Esbag O, Yazilitas D, Tanrıverdi O, Bilici A, Arpaci E, Berk V, Yetisyigit T, Ozdemir NY, Oztop I, Alacacioglu A, Aydin O, Ozcelik M, Yildirim E, Dinc N, Gumus M (2017) Evaluation of prognostic factors and adjuvant chemotherapy in patients with small bowel adenocarcinoma who underwent curative resection. Clin Colorectal Cancer 16:220–227. https://doi.org/10.1016/j.clcc.2016.08.002

    Article  PubMed  Google Scholar 

  13. Ecker BL, McMillan MT, Datta J, Mamtani R, Giantonio BJ, Dempsey DT, Fraker DL, Drebin JA, Karakousis GC, Roses RE (2016) Efficacy of adjuvant chemotherapy for small bowel adenocarcinoma: a propensity score-matched analysis. Cancer 122:693–701. https://doi.org/10.1002/cncr.29840

    Article  PubMed  Google Scholar 

  14. El-Khouly F, Khan MS, Toumpanakis C, Ogunbiyi G, Winslet M, Caplin M (2011) Morbidity & mortality associated with desmoplasia in midgut (carcinoid) neuroendocrine tumours. Gut 60:A109–A109. https://doi.org/10.1136/gut.2011.239301.228

    Article  Google Scholar 

  15. Sahani DV, Bonaffini PA, Fernández-Del Castillo C, Blake MA (2013) Gastroenteropancreatic neuroendocrine tumors: role of imaging in diagnosis and management. Radiology 266:38–61. https://doi.org/10.1148/radiol.12112512

    Article  PubMed  Google Scholar 

  16. Woodbridge LR, Murtagh BM, Yu DFQC, Planche KL (2014) Midgut neuroendocrine tumors: imaging assessment for surgical resection. RadioGraphics 34:413–426. https://doi.org/10.1148/rg.342135504

    Article  PubMed  Google Scholar 

  17. Almond LM, Hodson J, Ford SJ, Gourevitch D, Roberts KJ, Shah T et al (2017) Role of palliative resection of the primary tumour in advanced pancreatic and small intestinal neuroendocrine tumours: a systematic review and meta-analysis. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 43:1808–1815. https://doi.org/10.1016/j.ejso.2017.05.016

    Article  CAS  Google Scholar 

  18. Blažević A, Zandee WT, Franssen GJH, Hofland J, van Velthuysen M-LF, Hofland LJ et al (2018) Mesenteric fibrosis and palliative surgery in small intestinal neuroendocrine tumours. Endocr Relat Cancer 25:245–254. https://doi.org/10.1530/ERC-17-0282

    Article  PubMed  Google Scholar 

  19. Laskaratos FM, Diamantopoulos L, Walker M, Walton H, Khalifa M, El-Khouly F et al (2018) Prognostic factors for survival among patients with small bowel neuroendocrine Tumours associated with mesenteric Desmoplasia. Neuroendocrinology 106:366–380. https://doi.org/10.1159/000486097

    Article  CAS  PubMed  Google Scholar 

  20. Burkill GJC, Badran M, Al-Muderis O, Meirion Thomas J, Judson IR, Fisher C et al (2003) Malignant gastrointestinal stromal tumor: distribution, imaging features, and pattern of metastatic spread. Radiology 226:527–532. https://doi.org/10.1148/radiol.2262011880

    Article  PubMed  Google Scholar 

  21. Judson I, Bulusu R, Seddon B, Dangoor A, Wong N, Mudan S (2017) UK clinical practice guidelines for the management of gastrointestinal stromal tumours (GIST). Clin Sarcoma Res 7:6. https://doi.org/10.1186/s13569-017-0072-8

    Article  PubMed  PubMed Central  Google Scholar 

  22. Wong NA, Young R, Malcomson RDG, Nayar AG, Jamieson LA, Save VE et al (2003) Prognostic indicators for gastrointestinal stromal tumours: a clinicopathological and immunohistochemical study of 108 resected cases of the stomach. Histopathology 43:118–126. https://doi.org/10.1046/j.1365-2559.2003.01665.x

    Article  CAS  PubMed  Google Scholar 

  23. Fletcher CDM, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, Miettinen M, O'Leary TJ, Remotti H, Rubin BP, Shmookler B, Sobin LH, Weiss SW (2002) Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 33:459–465

    Article  PubMed  Google Scholar 

  24. Joensuu H (2008) Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol 39:1411–1419. https://doi.org/10.1016/j.humpath.2008.06.025

    Article  PubMed  Google Scholar 

  25. Joensuu H, Vehtari A, Riihimäki J, Nishida T, Steigen SE, Brabec P, Plank L, Nilsson B, Cirilli C, Braconi C, Bordoni A, Magnusson MK, Linke Z, Sufliarsky J, Federico M, Jonasson JG, Dei Tos AP, Rutkowski P (2012) Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. Lancet Oncol 13:265–274. https://doi.org/10.1016/S1470-2045(11)70299-6

    Article  PubMed  Google Scholar 

  26. Saeed A, Buell JF, Kandil E (2013) Surgical treatment of liver metastases in patients with neuroendocrine tumors. Ann Transl Med 1:6. https://doi.org/10.3978/j.issn.2305-5839.2013.01.08

    Article  PubMed  PubMed Central  Google Scholar 

  27. Xu H, Chen L, Shao Y, Zhu D, Zhi X, Zhang Q, Li F, Xu J, Liu X, Xu Z (2018) Clinical application of circulating tumor DNA in the genetic analysis of patients with advanced GIST. Mol Cancer Ther 17:290–296. https://doi.org/10.1158/1535-7163.MCT-17-0436

    Article  CAS  PubMed  Google Scholar 

  28. Li Q, Zhi X, Zhou J, Tao R, Zhang J, Chen P et al (2016) Circulating tumor cells as a prognostic and predictive marker in gastrointestinal stromal tumors: a prospective study. Oncotarget 7:36645–36654. https://doi.org/10.18632/oncotarget.9128

    Article  PubMed  PubMed Central  Google Scholar 

  29. Xie X, Zhou Z, Song Y, Dang C, Zhang H (2017) Surgical management and prognostic prediction of adenocarcinoma of jejunum and ileum. Sci Rep 7:15163. https://doi.org/10.1038/s41598-017-15633-w

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

No grant funding was received to complete this project.

Author information

Authors and Affiliations

  1. East kent hospital university NHS foundation trust, Ethelbert Rd, Canterbury, CT1 3NG, UK

    Duaa Gumaa

  2. Oxford university hospitals, Headley Way, Headington, Oxford, OX3 9DU, UK

    Alex Gordon-Weeks

  3. Department of Hepatobiliary and Pancreatic Surgery, Churchill Hospital, Oxford, UK

    Michael Silva

Authors
  1. Duaa Gumaa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alex Gordon-Weeks
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Duaa Gumaa.

Ethics declarations

Conflict of Interest

The authors do not have any conflict of interest to declare.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 268 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gumaa, D., Gordon-Weeks, A. & Silva, M. Small Bowel Tumors – Case Series Analysis: Prognostic Factors and Survivals. Indian J Surg 82, 662–668 (2020). https://doi.org/10.1007/s12262-020-02092-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12262-020-02092-3

Keywords

Search

Navigation